| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
ID: ALA4542338
Max Phase: Preclinical
Molecular Formula: C15H15BrN2O3S
Molecular Weight: 383.27
Molecule Type: Unknown
Associated Items:
Representations
Canonical SMILES: O=C(CNS(=O)(=O)Cc1ccccc1)Nc1cccc(Br)c1
Standard InChI: InChI=1S/C15H15BrN2O3S/c16-13-7-4-8-14(9-13)18-15(19)10-17-22(20,21)11-12-5-2-1-3-6-12/h1-9,17H,10-11H2,(H,18,19)
Standard InChI Key: HEUZAFXSCKUENO-UHFFFAOYSA-N
Associated Targets(Human)
Serine racemase 249 Activities
Molecule Features
| Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
| Molecule Type: Unknown | Topical: No | First In Class: No | Black Box: No |
| Chirality: No | Availability: No | Prodrug: No |
Drug Indications
| MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
|---|
Mechanisms of Action
| Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
|---|
Properties
| Molecular Weight: 383.27 | Molecular Weight (Monoisotopic): 381.9987 | AlogP: 2.51 | #Rotatable Bonds: 6 |
| Polar Surface Area: 75.27 | Molecular Species: NEUTRAL | HBA: 3 | HBD: 2 |
| #RO5 Violations: 0 | HBA (Lipinski): 5 | HBD (Lipinski): 2 | #RO5 Violations (Lipinski): 0 |
| CX Acidic pKa: 8.77 | CX Basic pKa: | CX LogP: 2.25 | CX LogD: 2.23 |
| Aromatic Rings: 2 | Heavy Atoms: 22 | QED Weighted: 0.81 | Np Likeness Score: -1.97 |
References
| 1. (2014) Serine racemase inhibitor, |
Source
Source(1):